Navigating immune cell immunometabolism after liver transplantation

Crit Rev Oncol Hematol. 2021 Apr:160:103227. doi: 10.1016/j.critrevonc.2021.103227. Epub 2021 Mar 3.

Abstract

Liver transplantation (LT) is the most effective treatment for end-stage liver diseases. The immunometabolism microenvironment undergoes massive changes at the interface of immune functionalities and metabolic regulations after LT. These changes considerably modify post-transplant complications, and immune cells play an influential role in the hepatic immunometabolism microenvironment after LT. Therefore, adequate studies on the complex pathobiology of immune cells are critical to prevent post-transplant complications, and the interplay between cellular metabolism and immune function is evident. Furthermore, immune cells perform their specified functions, such as activation or differentiation, accompanied by alterations in metabolic pathways, such as metabolic reprogramming. This transformation remarkably affects post-transplant complications like rejection. By targeting different metabolic pathways, regulations of metabolism are employed to shape immune responses. These differences of metabolic pathways allow for selective regulation of immune responses to further develop effective therapies that prevent graft loss after LT. This review examines immune cells in the hepatic immunometabolism microenvironment after LT, summarizes possible mechanisms and potential prevention on rejection to acquire immune tolerance, and offers some insight into references for scientific research along with clinical treatment.

Keywords: Immune cells; Immune tolerance; Immunometabolism; Liver transplantation; Metabolic reprogramming.

Publication types

  • Review

MeSH terms

  • Humans
  • Immune Tolerance
  • Immunity
  • Liver Transplantation*
  • Metabolic Networks and Pathways